Grant: Project Grant - PA: Antimicrobial Resistance (Bridge Grant)
McGill University
$100,000.00
Regulating the Response: Targeting Virulence Factors Secretion by the Type IX Secretion System
FY 2022-23
Summary
Pathogenic bacteria utilize sophisticated secretion systems to transport their virulence factors across membrane(s) and manipulate their infected host. In an ever-increasing antibiotic resistance era, bacterial virulence factors, and their designated transportation systems are a novel group of antimicrobial drug targets to augment our current antibiotics repertoire and allow effective treatment. One secretion system with a tremendous, yet unexplored, potential
is the type-IX secretion system (T9SS). Porphyromonas gingivalis is a notorious human oral pathogen and a primary causative agent of periodontitis that utilizes its T9SS to promote host cell manipulation and infection. P. gingivalis infection was found to be directly linked to major systemic conditions, such as cardiovascular diseases, preterm low birth weight, rheumatoid arthritis, non-alcoholic fatty liver disease, cancer, and Alzheimer's disease. Elucidation of the underlying molecular mechanisms promoting the T9SS virulence is imminent in light of the growing evidence linking periodontitis to these systemic human diseases. Therefore, this research plan aims to elucidate the structure-function relationship of the T9SS. The obtained structural information will direct a tailored research strategy combining biochemical, biophysical, and genetic approaches to elucidate mechanistic details of the T9SS, culminating in the development of new therapeutics for the treatment of infectious diseases.
Department
Program
Project Grant - PA: Antimicrobial Resistance (Bridge Grant)
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
472343
Name
Zeytuni Natalie
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Biochemistry & Molecular Biology - A
Projecttitle
Regulating the Response: Targeting Virulence Factors Secretion by the Type IX Secretion System
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - PA: Antimicrobial Resistance (Bridge Grant)
Keyworddelim
Alkaline Phospatase; Antibiotic Resistance; Bacterial Pathogenicity; Bacterial Secretion Systems; Oral Pathogens; Porphyromonas Gingivalis; Response Regulators; Structure-Function Studeis; Two-Component Systems; X-Ray Crystallography
Abstract
Pathogenic bacteria utilize sophisticated secretion systems to transport their virulence factors across membrane(s) and manipulate their infected host. In an ever-increasing antibiotic resistance era, bacterial virulence factors, and their designated transportation systems are a novel group of antimicrobial drug targets to augment our current antibiotics repertoire and allow effective treatment. One secretion system with a tremendous, yet unexplored, potential
is the type-IX secretion system (T9SS). Porphyromonas gingivalis is a notorious human oral pathogen and a primary causative agent of periodontitis that utilizes its T9SS to promote host cell manipulation and infection. P. gingivalis infection was found to be directly linked to major systemic conditions, such as cardiovascular diseases, preterm low birth weight, rheumatoid arthritis, non-alcoholic fatty liver disease, cancer, and Alzheimer's disease. Elucidation of the underlying molecular mechanisms promoting the T9SS virulence is imminent in light of the growing evidence linking periodontitis to these systemic human diseases. Therefore, this research plan aims to elucidate the structure-function relationship of the T9SS. The obtained structural information will direct a tailored research strategy combining biochemical, biophysical, and genetic approaches to elucidate mechanistic details of the T9SS, culminating in the development of new therapeutics for the treatment of infectious diseases.
Competitiondate
202209
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zeytuni, Natalie
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~